APOMAB Trademark

Trademark Overview


On Thursday, May 5, 2005, a trademark application was filed for APOMAB with the United States Patent and Trademark Office. The USPTO has given the APOMAB trademark a serial number of 79018255. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, May 5, 2025. This trademark is owned by Medvet Science Pty Ltd. The APOMAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, for health care, all the foregoing for the treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; pharmaceutical products and preparations of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, for radio-immuno-diagnosis or radio-immuno-therapy, the foregoing for the diagnosis and treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; pharmaceutical preparations used in the therapy and diagnosis of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; diagnostic preparations for detecting the presence of malignant, inflammato...
apomab

General Information


Serial Number79018255
Word MarkAPOMAB
Filing DateThursday, May 5, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, May 5, 2025
Registration Number3356510
Registration DateTuesday, December 18, 2007
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 2, 2007

Trademark Statements


Goods and ServicesPharmaceutical products and preparations of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, for health care, all the foregoing for the treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; pharmaceutical products and preparations of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, for radio-immuno-diagnosis or radio-immuno-therapy, the foregoing for the diagnosis and treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; pharmaceutical preparations used in the therapy and diagnosis of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; diagnostic preparations for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia in humans, the foregoing for medical use; monoclonal antibodies and fragments thereof for cancer research and pharmaceutical development, biomedical research, [ veterinary vaccines, ]veterinary diagnostic and treatment purposes, clinical trials for cancer pharmaceuticals, cancer diagnosis and cancer therapy purposes; cultures and preparations of hybridoma and other cells for medical, diagnostic and veterinary purposes; medicinal products of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, the foregoing for the treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, May 4, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAushealth Corporate Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameMedvet Science Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameMedvet Science Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Thursday, December 22, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 27, 2005NEW APPLICATION ENTERED
Tuesday, December 27, 2005ASSIGNED TO EXAMINER
Friday, December 30, 2005NON-FINAL ACTION WRITTEN
Saturday, December 31, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 10, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 27, 2006REFUSAL PROCESSED BY IB
Monday, June 26, 2006PAPER RECEIVED
Monday, June 26, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 25, 2006AMENDMENT FROM APPLICANT ENTERED
Monday, August 14, 2006FINAL REFUSAL WRITTEN
Monday, August 14, 2006FINAL REFUSAL MAILED
Monday, February 12, 2007PAPER RECEIVED
Tuesday, March 20, 2007ASSIGNED TO LIE
Monday, February 12, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 21, 2007AMENDMENT FROM APPLICANT ENTERED
Thursday, April 19, 2007NON-FINAL ACTION WRITTEN
Thursday, April 19, 2007NON-FINAL ACTION MAILED
Thursday, May 24, 2007NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, May 24, 2007NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, June 7, 2007NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, June 29, 2007PAPER RECEIVED
Tuesday, July 3, 2007ASSIGNED TO LIE
Tuesday, August 21, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 21, 2007AMENDMENT FROM APPLICANT ENTERED
Tuesday, August 21, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 27, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 12, 2007NOTICE OF PUBLICATION
Tuesday, October 2, 2007PUBLISHED FOR OPPOSITION
Tuesday, December 18, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, March 18, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 2, 2008FINAL DISPOSITION PROCESSED
Wednesday, April 2, 2008FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 4, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 10, 2013TEAS SECTION 71 & 15 RECEIVED
Thursday, December 26, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 10, 2013REGISTERED - SEC. 71 & SEC. 15 FILED
Thursday, December 26, 2013REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, December 26, 2013NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, May 21, 2015INTERNATIONAL REGISTRATION RENEWED
Sunday, December 18, 2016COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, December 15, 2017TEAS SECTION 71 RECEIVED
Thursday, December 21, 2017REGISTERED-SEC.71 ACCEPTED
Thursday, December 21, 2017NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, August 21, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, September 6, 2018INVALIDATION PROCESSED
Thursday, September 6, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, October 19, 2018PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, March 1, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, November 30, 2025DEATH OF INTERNATIONAL REGISTRATION
Sunday, November 30, 2025NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED